Genedata Biologics 1.5 simplifies data exchange by providing a collaboration platform for pharmaceutical, biotechnology, and technology companies, contract research organizations (CROs) and academic networks. The platform helps to
Following EC’s approval, the company is now set to launch the spray in September 2011. Developed by Nycomed, Instanyl fentanyl nasal spray will be launched in 50µg, 100µg,
The NDA submission was done on the basis of positive results from different trials which demonstrated that Defibrotide does not appear to increase the risk of complications in
The award has been granted to the Duke Cancer Institute Medicine associate professor Herb Hurwitz. The Duke Cancer Institute plans to commence a Phase 1 clinical trial of
As part of the agreement, Innate Pharma will offer pre-clinical support to Bristol-Myers Squibb. Bristol-Myers Squibb will get exclusive worldwide rights to IPH2102 and related compounds. The agreement
Simplicity EMR is a web-based EMR/EHR software system which is used to record, retrieve, and archive patient medical records instantly, anytime, anywhere. The company has obtained federal government’s
As per the terms of the agreement, Cambrex has sold the development and commercialization rights for the drug products to Tillotts which are based on 5-ASA-based technology. In
Further, Karl-Hermann Schlingensiepen, the current CEO of the company, has changed from the operative management of Antisense Pharma to a strategic consulting function. He will concentrate on consulting
In addition to that the company expects to begin a Phase 2 trial to evaluate combination of TMC435 and Pharmasset’s PSI-7977 for CHC treatment. The primary endpoint of
The antimicrobial solution found in the Ophthalmic Wash and Otic Rinse inhibits antibiotic-resistant strains of bacteria (including staph and MRSA) as well as fungi, viruses and spores. Innovacyn
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.